Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2010, Article ID 254316, 5 pages
http://dx.doi.org/10.1155/2010/254316
Case Report

Treatment of Complicated Henoch-Schönlein Purpura with Mycophenolate Mofetil: A Retrospective Case Series Report

Department of Pediatric Nephrology, Urmia University School of Medicine, Iran

Received 27 December 2009; Revised 28 March 2010; Accepted 30 April 2010

Academic Editor: Malcolm Smith

Copyright © 2010 A. A. Nikibakhsh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. T. Saulsbury, “Epidemiology of Henoch-Schönlein purpura,” Cleveland Clinic Journal of Medicine, vol. 69, no. 2, pp. 87–89, 2002. View at Google Scholar · View at Scopus
  2. S. Ozen, N. Ruperto, and N. Ruperto, “EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides,” Annals of the Rheumatic Diseases, vol. 65, no. 7, pp. 936–941, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. Y. K. Abdel-Al, Z. Hejazi, and H. A. Majeed, “Henoch-Schönlein purpura in Arab children. Analysis of 52 cases,” Tropical and Geographical Medicine, vol. 42, no. 1, pp. 52–57, 1990. View at Google Scholar · View at Scopus
  4. E. J. Tizard and M. J. J. Hamilton-Ayres, “Henoch-Schönlein purpura,” Archives of Disease in Childhood, vol. 93, no. 1, pp. 1–8, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. M. Huber, J. King, P. McLaine, T. Klassen, and M. Pothos, “A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura,” BMC Medicine, vol. 2, article 7, 2004. View at Publisher · View at Google Scholar · View at PubMed
  6. M. Haroon, “Should children with Henoch-Schönlein purpura and abdominal pain be treated with steroids?” Archives of Disease in Childhood, vol. 90, no. 11, pp. 1196–1198, 2005. View at Google Scholar · View at Scopus
  7. J. Ronkainen, O. Koskimies, and O. Koskimies, “Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial,” Journal of Pediatrics, vol. 149, no. 2, pp. 241–247, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. Y. Kaku, K. Nohara, and S. Honda, “Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors,” Kidney International, vol. 53, no. 6, pp. 1755–1759, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. F. Mollica, S. Li Volti, R. Garozzo, and G. Russo, “Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura,” European Journal of Pediatrics, vol. 151, no. 2, pp. 140–144, 1992. View at Google Scholar · View at Scopus
  10. P. Niaudet and R. Habib, “Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis,” Pediatric Nephrology, vol. 12, no. 3, pp. 238–243, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Narchi, “Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review,” Archives of Disease in Childhood, vol. 90, no. 9, pp. 916–920, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. R. Benfield, J. M. Symons, S. Bynon, D. Eckhoff, J. Herrin, W. Harmon, and E. Kohaut, “Mycophenolate mofetil in pediatric renal transplantation,” Pediatric Transplantation, vol. 3, no. 1, pp. 33–37, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Dede, B. Onec, D. Ayli, I. I. Gonul, and K. Onec, “Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions,” Scandinavian Journal of Urology and Nephrology, vol. 42, no. 2, pp. 178–180, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. S. Martin, C. H. Cramer, J. Heikenen, and J. J. Gitomer, “Gastrointestinal symptoms of Henoch-Schönlein purpura treated with mycophenolate mofetil,” Journal of Pediatric Gastroenterology and Nutrition, vol. 43, no. 2, pp. 245–247, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. Mendizábal, I. Zamora, O. Berbel, M. J. Sanahuja, J. Fuentes, and J. Simon, “Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome,” Pediatric Nephrology, vol. 20, no. 7, pp. 914–919, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. W. Hu, C. Liu, H. Xie, H. Chen, Z. Liu, and L. Li, “Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement,” Nephrology Dialysis Transplantation, vol. 23, no. 4, pp. 1307–1312, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. Muzaffar, A. Taj, and N. Sethi, “Kaw rapidly progressing glomerulonephritis secondary to Henoch-Schönlein purpura treated with mycophenolate mofetil: a case report with atypical etiology and presentation,” to appear in American Journal of Therapeutics.
  18. R. F. Andersen, S. Rubak, B. Jespersen, and S. Rittig, “Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome,” Scandinavian Journal of Urology and Nephrology, vol. 43, no. 5, pp. 409–415, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. G. Filler, M. Hansen, C. LeBlanc, N. Lepage, D. Franke, I. Mai, and J. Feber, “Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children,” Pediatric Nephrology, vol. 18, no. 5, pp. 445–449, 2003. View at Google Scholar · View at Scopus
  20. P. F. Weiss, J. A. Feinstein, X. Luan, J. M. Burnham, and C. Feudtner, “Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review,” Pediatrics, vol. 120, no. 5, pp. 1079–1087, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. R. Bogdanović, “Henoch-Schönlein purpura nephritis in children: risk factors, prevention and treatment,” Acta Paediatrica, vol. 98, no. 12, pp. 1882–1889, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. H. W. Sollinger, “Mycophenolates in transplantation,” Clinical Transplantation, vol. 18, no. 5, pp. 485–492, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. P. M. Stassen, C. G. M. Kallenberg, and C. A. Stegeman, “Use of mycophenolic acid in non-transplant renal diseases,” Nephrology Dialysis Transplantation, vol. 22, no. 4, pp. 1013–1019, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus